These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

800 related articles for article (PubMed ID: 26371147)

  • 1. Comparison of the Genomic Landscape Between Primary Breast Cancer in African American Versus White Women and the Association of Racial Differences With Tumor Recurrence.
    Keenan T; Moy B; Mroz EA; Ross K; Niemierko A; Rocco JW; Isakoff S; Ellisen LW; Bardia A
    J Clin Oncol; 2015 Nov; 33(31):3621-7. PubMed ID: 26371147
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Differences in the mutational landscape of triple-negative breast cancer in African Americans and Caucasians.
    Ademuyiwa FO; Tao Y; Luo J; Weilbaecher K; Ma CX
    Breast Cancer Res Treat; 2017 Feb; 161(3):491-499. PubMed ID: 27915434
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of Breast Cancer Molecular Features and Survival by African and European Ancestry in The Cancer Genome Atlas.
    Huo D; Hu H; Rhie SK; Gamazon ER; Cherniack AD; Liu J; Yoshimatsu TF; Pitt JJ; Hoadley KA; Troester M; Ru Y; Lichtenberg T; Sturtz LA; Shelley CS; Benz CC; Mills GB; Laird PW; Shriver CD; Perou CM; Olopade OI
    JAMA Oncol; 2017 Dec; 3(12):1654-1662. PubMed ID: 28472234
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Race-associated biological differences among luminal A and basal-like breast cancers in the Carolina Breast Cancer Study.
    Parada H; Sun X; Fleming JM; Williams-DeVane CR; Kirk EL; Olsson LT; Perou CM; Olshan AF; Troester MA
    Breast Cancer Res; 2017 Dec; 19(1):131. PubMed ID: 29228969
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Basal cell-like (triple-negative) breast cancer, a predictor of distant metastasis in African American women.
    Ihemelandu CU; Naab TJ; Mezghebe HM; Makambi KH; Siram SM; Leffall LD; Dewitty RL; Frederick WA
    Am J Surg; 2008 Feb; 195(2):153-8. PubMed ID: 18083134
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Enhanced immortalization, HUWE1 mutations and other biological drivers of breast invasive carcinoma in Black/African American patients.
    Andey T; Attah MM; Akwaaba-Reynolds NA; Cheema S; Parvin-Nejad S; Acquaah-Mensah GK
    Gene; 2020 Dec; 763S():100030. PubMed ID: 34493366
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Racial and Ethnic Differences in Breast Cancer Survival: Mediating Effect of Tumor Characteristics and Sociodemographic and Treatment Factors.
    Warner ET; Tamimi RM; Hughes ME; Ottesen RA; Wong YN; Edge SB; Theriault RL; Blayney DW; Niland JC; Winer EP; Weeks JC; Partridge AH
    J Clin Oncol; 2015 Jul; 33(20):2254-61. PubMed ID: 25964252
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Somatic mutations of triple-negative breast cancer: a comparison between Black and White women.
    Omilian AR; Wei L; Hong CC; Bandera EV; Liu S; Khoury T; Ambrosone CB; Yao S
    Breast Cancer Res Treat; 2020 Jul; 182(2):503-509. PubMed ID: 32441016
    [TBL] [Abstract][Full Text] [Related]  

  • 9. 21-Gene recurrence scores: racial differences in testing, scores, treatment, and outcome.
    Lund MJ; Mosunjac M; Davis KM; Gabram-Mendola S; Rizzo M; Bumpers HL; Hearn S; Zelnak A; Styblo T; O'Regan RM
    Cancer; 2012 Feb; 118(3):788-96. PubMed ID: 21720988
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Alcohol intake and invasive breast cancer risk by molecular subtype and race in the Carolina Breast Cancer Study.
    Williams LA; Olshan AF; Tse CK; Bell ME; Troester MA
    Cancer Causes Control; 2016 Feb; 27(2):259-69. PubMed ID: 26705260
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Genomic analysis of racial differences in triple negative breast cancer.
    Chang CS; Kitamura E; Johnson J; Bollag R; Hawthorn L
    Genomics; 2019 Dec; 111(6):1529-1542. PubMed ID: 30366040
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Outcomes of Hormone-Receptor Positive, HER2-Negative Breast Cancers by Race and Tumor Biological Features.
    Benefield HC; Reeder-Hayes KE; Nichols HB; Calhoun BC; Love MI; Kirk EL; Geradts J; Hoadley KA; Cole SR; Earp HS; Olshan AF; Carey LA; Perou CM; Troester MA
    JNCI Cancer Spectr; 2021 Feb; 5(1):. PubMed ID: 33442657
    [TBL] [Abstract][Full Text] [Related]  

  • 13. High expression of MKK3 is associated with worse clinical outcomes in African American breast cancer patients.
    Yang X; Amgad M; Cooper LAD; Du Y; Fu H; Ivanov AA
    J Transl Med; 2020 Sep; 18(1):334. PubMed ID: 32873298
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Breast Cancer Mortality in African-American and Non-Hispanic White Women by Molecular Subtype and Stage at Diagnosis: A Population-Based Study.
    Tao L; Gomez SL; Keegan TH; Kurian AW; Clarke CA
    Cancer Epidemiol Biomarkers Prev; 2015 Jul; 24(7):1039-45. PubMed ID: 25969506
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Racial disparities in breast cancer diagnosis and treatment by hormone receptor and HER2 status.
    Chen L; Li CI
    Cancer Epidemiol Biomarkers Prev; 2015 Nov; 24(11):1666-72. PubMed ID: 26464428
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Racial differences in the incidence of BRCA1 and BRCA2 mutations in a cohort of early onset breast cancer patients: African American compared to white women.
    Haffty BG; Silber A; Matloff E; Chung J; Lannin D
    J Med Genet; 2006 Feb; 43(2):133-7. PubMed ID: 15983021
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Molecular breast cancer subtypes in premenopausal African-American women, tumor biologic factors and clinical outcome.
    Ihemelandu CU; Leffall LD; Dewitty RL; Naab TJ; Mezghebe HM; Makambi KH; Adams-Campbell L; Frederick WA
    Ann Surg Oncol; 2007 Oct; 14(10):2994-3003. PubMed ID: 17647064
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mortality risk of black women and white women with invasive breast cancer by hormone receptors, HER2, and p53 status.
    Ma H; Lu Y; Malone KE; Marchbanks PA; Deapen DM; Spirtas R; Burkman RT; Strom BL; McDonald JA; Folger SG; Simon MS; Sullivan-Halley J; Press MF; Bernstein L
    BMC Cancer; 2013 May; 13():225. PubMed ID: 23642215
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Race-associated biological differences among Luminal A breast tumors.
    D'Arcy M; Fleming J; Robinson WR; Kirk EL; Perou CM; Troester MA
    Breast Cancer Res Treat; 2015 Jul; 152(2):437-48. PubMed ID: 26109344
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Association of Social Determinants and Tumor Biology With Racial Disparity in Survival From Early-Stage, Hormone-Dependent Breast Cancer.
    Hoskins KF; Calip GS; Huang HC; Ibraheem A; Danciu OC; Rauscher GH
    JAMA Oncol; 2023 Apr; 9(4):536-545. PubMed ID: 36795405
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 40.